检察机关认为，永安化工环保部员工关吉标干扰排污自动监测设施，致使监测数据严重失真，被告单位永安化工排放大气污染物，应当以污染环境罪追究 刑事责任。相关案件已向江苏省灌南县人民法院提起公诉。 贝斯美在公告中表示，永安化工的生产经营活动正常开展，暂无法判断上述案件对永安化工及公司本期利润或期后利润的影响情况。针对此次诉讼的问题 事项，永安化工已在2024年完成整改，去年2月重新申请排污许可证并获得淮安市生态环境局审核通过。 《每日经济新闻》记者注意到，永安化工主营农药产品的生产和销售，产品主要为二甲戊灵原药、制剂。2024年，永安化工的净利润"大变脸"，全年亏损 57.13万元；2025年上半年，永安化工的营收为2.45亿元，净利润744.09万元。 每经记者｜陈鹏丽 每经编辑｜陈柯名 廖丹 1月7日晚，贝斯美（SZ300796）公告称，公司全资子公司江苏永安化工有限公司（以下简称永安化工）收到江苏省涟水县人民检察院出具的《起诉 书》。 官网截图 子公司被提起公诉 公告显示，江苏省涟水县人民检察院对永安化工提起公诉。检察院认为，永安化工应当以污染环境罪追究刑事责任。根据检察机关查明的事实及相关法律 规定，永安化工 ...

1月7日，贝斯美（300796）发布公告称，全资子公司收到检察机关起诉书。 公告显示，近日，绍兴贝斯美化工股份有限公司全资子公司江苏永安化工有限公司(简称"永安化工")收到江苏省涟水县人民检察院出具的《起诉书》。 检察机关认为，被告人环保部员工关吉标干扰排污自动监测设施，致使监测数据严重失真，被告单位永安化工排放大气污染物，应当以污染环境罪追究刑 事责任。 贝斯美表示，截至公告披露日，永安化工的生产经营活动正常开展，上述案件尚未审结，暂无法判断对永安化工及公司本期利润或期后利润的影响情况。 贝斯美同时称，针对此次诉讼的问题事项，永安化工已在2024年完成整改，同时请三方监测公司进行排放数据监测合格后，2025年2月25日重新申请排污 许可证并获得淮安市生态环境局审核通过。 根据检察机关查明的事实及相关法律规定，永安化工及涉案人员具有明确的从轻、从宽处罚情节，同时建议可以从轻、从宽处理。相关案件已向江苏省灌 南县人民法院提起公诉。 资料显示，永安化工主要业务为二甲戊灵原药、制剂的生产和销售，2025年上半年，其净利润为744.09万元。 贝斯美主营业务涵盖自产农药业务、农药出海业务和碳五新材料业务三大板块。20 ...

截至9月30日，贝斯美股东户数1.80万，较上期减少9.41%；人均流通股20046股，较上期增加10.39%。 2025年1月-9月，贝斯美实现营业收入11.10亿元，同比增长14.29%；归母净利润3116.67万元，同比增长 1257.94%。 分红方面，贝斯美A股上市后累计派现6287.00万元。近三年，累计派现3852.19万元。 责任编辑：小浪快报 贝斯美今年以来股价跌13.61%，近5个交易日涨2.56%，近20日跌3.08%，近60日跌10.82%。 资料显示，绍兴贝斯美化工股份有限公司位于浙江省绍兴市上虞区杭州湾上虞经济技术开发区经十一路 2号，成立日期2003年3月31日，上市日期2019年11月15日，公司主营业务涉及以4-硝等中间体、二甲戊 灵原药和二甲戊灵制剂等产品为主的研发、生产及销售。主营业务收入构成为：二甲戊灵原药 25.95%，贸易类除草剂25.54%，贸易类杀虫剂18.91%，贸易类杀菌剂9.83%，碳五系列产品7.89%，农 药中间体4.99%，二甲戊灵制剂4.25%，贸易类其他化工产品2.59%，其它0.05%。 贝斯美所属申万行业为：基础化工-农化制品-农药。所属概念 ...

Group 1 - The core stock price of Beishimei increased by 2.07% on November 19, reaching 9.86 CNY per share, with a total market capitalization of 3.561 billion CNY [1] - The company experienced a stock price decline of 3.43% year-to-date, but saw a 1.75% increase over the last five trading days and a 2.28% increase over the last 20 days, while it dropped 19.51% over the last 60 days [2] - As of September 30, the number of shareholders decreased by 9.41% to 18,000, with an average of 20,046 circulating shares per person, which increased by 10.39% [2] Group 2 - Beishimei's main business includes the research, production, and sales of products such as 4-nitro intermediates, dimethenamid-p active ingredients, and dimethenamid-p formulations, with the main revenue sources being dimethenamid-p active ingredients (25.95%) and various trade pesticides [2] - For the period from January to September 2025, Beishimei achieved operating revenue of 1.11 billion CNY, representing a year-on-year growth of 14.29%, and a net profit attributable to shareholders of 31.17 million CNY, reflecting a significant year-on-year increase of 1257.94% [2] - The company has distributed a total of 62.87 million CNY in dividends since its A-share listing, with 38.52 million CNY distributed over the past three years [3]

Core Viewpoint - Beishimei, established in 2003 and listed in 2019, is a domestic pesticide company focusing on R&D, production, and sales, with a differentiated advantage across the entire industry chain [1] Group 1: Business Performance - In Q3 2025, Beishimei reported revenue of 1.11 billion yuan, ranking 23rd among 32 companies in the industry, with the industry leader, ADAMA, at 21.678 billion yuan [2] - The net profit for the same period was 28.547 million yuan, also ranking 23rd, while the industry leader, Yangnong Chemical, achieved a net profit of 1.056 billion yuan [2] Group 2: Financial Ratios - As of Q3 2025, Beishimei's debt-to-asset ratio was 45.47%, an increase from 42.14% year-on-year, but still below the industry average of 46.06% [3] - The gross profit margin for Q3 2025 was 17.44%, up from 14.40% year-on-year, yet lower than the industry average of 21.70% [3] Group 3: Executive Compensation - The chairman and general manager, Zhong Xijun, received a salary of 610,800 yuan in 2024, a slight increase from 608,500 yuan in 2023 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 9.41% to 18,000, while the average number of circulating A-shares held per account increased by 10.39% to 20,000 [5]

Core Viewpoint - The company has successfully achieved stable production and bulk sales of its carbon five derivative products, including cyclopentane and pentene, while also progressing in the construction of specialty alcohols and maintaining global sales of dimethyl pentyl herbicide [2]. Group 1: Product Sales and Production - The cyclopentane series project has achieved stable production and bulk sales [2]. - Pentene, as a by-product of the ketone unit, has an annual production capacity of 4,000 tons, with normal production and sales ongoing [2]. Group 2: Project Development - The "20,000 tons per year specialty alcohol series green new materials project" has entered the construction phase and is progressing as planned [2]. Group 3: Global Sales - The company, through its wholly-owned subsidiary Ningbo Jielike, is conducting global sales of dimethyl pentyl herbicide, with product coverage expected to reach 79 countries and regions by 2024 [2].

Core Viewpoint - The company, Baismei, has established a comprehensive industrial chain in its self-produced pesticide business, covering pesticide intermediates, active ingredients, and formulations, emphasizing technology research and development as a key driver for growth [2] Group 1: Business Operations - The company has a complete system for research and development, intermediate production, active ingredient synthesis, and formulation processing [2] - Baismei focuses on independent research and development, supplemented by collaborative development, ensuring continuous transformation of research results into productivity [2] Group 2: Product Quality - The core process technology developed by the company supports its production in various segments, with the concentration and impurity levels of its dimethyl tetrachloride active ingredient meeting or exceeding the standards and requirements of developed countries [2] Group 3: Market Expansion - The subsidiary, Ningbo Jielike, has established sales channels in 79 countries and regions, enhancing the company's ability to expand into international markets through its independent registration model and channel resources [2]

Core Viewpoint - The company, Bestme (贝斯美), has the capability to become a qualified strategic supplier for multinational pesticide companies due to its comprehensive production capabilities and advanced technology in pesticide manufacturing [1] Group 1: Production Capabilities - The company has a complete industrial chain covering pesticide intermediates, active ingredients, and formulations, supported by its own research and development [1] - The core process technology developed by the company allows its products, such as dimethenamid-p, to meet or exceed the standards and requirements of developed countries [1] Group 2: Research and Development - The company emphasizes technology research and development, primarily focusing on independent research while also engaging in collaborative development [1] - The continuous transformation of research results into production capabilities is a key aspect of the company's strategy [1] Group 3: Market Expansion - The subsidiary, Ningbo Jielike, has established sales channels in 79 countries and regions, enhancing the company's ability to expand into international markets [1] - The company's self-registration model and channel resources provide a richer resource base for international market expansion [1]

Core Points - The company Baisimei (SZ 300796) announced an incentive plan on September 10, which will grant a total of 116 individuals restricted stock, sourced from shares repurchased in the secondary market [1] - The total number of restricted shares to be granted is up to 5.6 million, representing approximately 1.55% of the company's total share capital of about 361 million shares at the time of the announcement [1] - The grant price for the restricted shares is set at 5.65 yuan per share, allowing recipients to purchase the shares at this price upon meeting vesting conditions, with a maximum validity period of 48 months [1] - For the first half of 2025, Baisimei's revenue composition is entirely from pesticide intermediates and the active ingredient of dimethomorph, indicating a focused business model [1] - As of the report date, Baisimei's market capitalization stands at 3.7 billion yuan [1]

Group 1 - The company Beishimei (SZ 300796) announced that its 11th meeting of the 4th board of directors will be held on September 10, 2025, to discuss matters related to stock incentive plans [1] - For the first half of 2025, Beishimei's revenue composition is entirely from pesticide intermediates and the active ingredient Dimethenamid-P, accounting for 100% [1] - As of the report date, Beishimei has a market capitalization of 3.7 billion yuan [1]